Current through Register Vol. XLI, No. 50, December 13, 2024
Section 11-8-2 - DefinitionsFor purposes of this rule, the following definitions apply:
2.1. "Boards" means the West Virginia Board of Pharmacy, the West Virginia Board of Medicine, and the West Virginia Board of Osteopathic Medicine.2.2. "Collaborating pharmacist" means a pharmacist licensed in West Virginia who has been verified by the Board of Pharmacy to engage in collaborative pharmacy practice: With one or more collaborating physicians:
Pursuant to a collaborative pharmacy practice agreement developed in accord with this rule; and
For which a complete and valid practice notification is filed with the boards.
2.3. "Collaborating physician" means a doctor of medicine or osteopathic medicine fully and actively licensed to practice clinical medicine, without restriction, in West Virginia by the Board of Medicine or the Board of Osteopathic Medicine who collaborates with pharmacists: Pursuant to a collaborative pharmacy practice agreement developed in accord with this rule; and
For which a complete and valid practice notification is filed with the boards.
A physician in training may also collaborate with pharmacists pursuant to an active collaborative pharmacy agreement if the trainee's supervising physician or medical department chair executes the collaborative pharmacy practice agreement and the physician in training collaborates under the supervision of the physician who executed the agreement.
2.4. "Collaborative pharmacy practice" is that practice of pharmacist care where one or more pharmacists have jointly agreed, on a voluntary basis, to work in conjunction with one or more physicians under written protocol where the pharmacist or pharmacists may perform certain patient care functions authorized by the physician or physicians under certain specified conditions and limitations.2.5. "Collaborative pharmacy practice agreement" is a written and signed agreement, which is a physician directed approach, that is entered into between an individual physician or physician group, or for a medical provider in training where the agreement is signed by the supervising physician or chairperson of the medical department where the medical provider in training is practicing, and an individual pharmacist or pharmacists that provides for collaborative pharmacy practice for the purpose of drug therapy management of a patient.2.6. "Collaborative pharmacy practice protocol" is the detailed written portion of the collaborative pharmacy practice agreement pursuant to which the authorized pharmacist will base drug therapy management decisions for patients.2.7. "Controlled substances" means drugs that are classified by federal or state law in Schedules I, II, III, IV or V, as defined in W. Va. Code Chapter 60A, Article 2.2.8. "Drug therapy management" means the review of drug therapy regimens of patients by a pharmacist for the purpose of evaluating and rendering advice to a physician regarding adjustment of the regimen in accordance with the collaborative pharmacy practice agreement. Decisions involving drug therapy management shall be made in the best interest of the patient. Drug therapy management is limited to:2.8.1. Implementing, modifying, and managing drug therapy according to the terms of the collaborative pharmacy practice agreement;2.8.2. Collecting and reviewing patient histories;2.8.3. Performing patient evaluations that are mutually agreed upon in the collaborative agreement; and2.8.4. Ordering screening laboratory tests that are dose related and specific to the patient's medication or are protocol driven and are also specifically set out in the collaborative pharmacy practice agreement between the pharmacist and physician.2.9. "Pharmacist Care" means the provision by a pharmacist of patient care activities, with or without the dispensing of drugs or devices, intended to achieve outcomes related to the cure or prevention of a disease, elimination, or reduction of a patient's symptoms, or arresting or slowing of a disease process and as provided for in W. Va. Code § 30-5-10. 2.10. "Pharmacist's scope of practice pursuant to the collaborative pharmacy practice agreement" means those duties and limitations of duties placed upon the pharmacist by the collaborating physician.2.11. "Practice notification" means a written notice to the appropriate licensing board that an individual physician or physician group or a medical provider in training where the agreement is signed by the supervising physician or chairperson of the medical department where the medical provider in training is practicing, and an individual pharmacist or pharmacists will practice in collaboration.2.12. "Website" means the set of related web pages operated by or on behalf of the boards located at the domain names of wvbop.com, wvbom.wv.gov, and wvbdosteo.org or at any successor domain name published by the boards.